Cargando…
Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol
BACKGROUND: Women infected with HIV have a risk of preterm birth (PTB) that is twice that among uninfected women, and treatment with antiretroviral therapy (ART) may further increase this risk. Progesterone supplementation reduces the risk of preterm delivery in women who have a shortened cervix in...
Autores principales: | Price, Joan T., Mollan, Katie R., Fuseini, Nurain M., Freeman, Bethany L., Mulenga, Helen B., Corbett, Amanda H., Vwalika, Bellington, Stringer, Jeffrey S. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516378/ https://www.ncbi.nlm.nih.gov/pubmed/28729911 http://dx.doi.org/10.1186/s40814-017-0170-7 |
Ejemplares similares
-
Vaginal progesterone to prevent preterm delivery among HIV-infected pregnant women in Zambia: A feasibility study
por: Price, Joan T., et al.
Publicado: (2020) -
Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study
por: Price, Joan T., et al.
Publicado: (2020) -
HIV-associated vaginal microbiome and inflammation predict spontaneous preterm birth in Zambia
por: Price, Joan T., et al.
Publicado: (2022) -
The Zambian Preterm Birth Prevention Study (ZAPPS): Cohort characteristics at enrollment
por: Castillo, Marcela C., et al.
Publicado: (2019) -
Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial
por: Price, Joan T., et al.
Publicado: (2019)